These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1672622)

  • 21. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
    Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
    Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
    Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
    Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
    Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vinblastine transport by membrane vesicles from human multidrug-resistant CCRF-CEM leukaemia cells: inhibition by taxol and membrane permeabilising agents.
    Syed SK; Christopherson RI; Roufogalis BD
    Biochem Mol Biol Int; 1993 Jul; 30(4):743-53. PubMed ID: 8104621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
    Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K; Tsuruo T
    Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells.
    Warren L; Malarska A; Jardillier JC
    Cancer Chemother Pharmacol; 1995; 35(3):267-9. PubMed ID: 7805188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.
    Bosch I; Dunussi-Joannopoulos K; Wu RL; Furlong ST; Croop J
    Biochemistry; 1997 May; 36(19):5685-94. PubMed ID: 9153408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM; Arnold ST; Felsted RL; Sinha BK
    Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
    Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitative cytological study of the activity of a new resistance modulator, S 9788, on human leukemic cells using multiparametric image analysis].
    Oum'Hamed Z; Berlion M; Millot-Broglio C; Dufer J; Joly P; Bizzari JP; Desplaces A
    Bull Cancer; 1994 Mar; 81(3):203-11. PubMed ID: 7894128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD; Carmeli S; Moore RE; Patterson GM
    Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
    Klohs WD; Steinkampf RW
    Mol Pharmacol; 1988 Aug; 34(2):180-5. PubMed ID: 2901030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM; Sinha BK
    Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
    Lelong IH; Guzikowski AP; Haugland RP; Pastan I; Gottesman MM; Willingham MC
    Mol Pharmacol; 1991 Oct; 40(4):490-4. PubMed ID: 1681415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.